Identifying Potential Human Carcinogens—The Role of Genetically Altered Rodents

Toxicologic Pathology

Volumn 25, Issue 2, 1997, Pages 241-243

  Ashby, John ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CARCINOGEN; CLOROFENE; MIREX;

BIOASSAY; CARCINOGEN TESTING; CHEMICAL CARCINOGENESIS; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE;

MUS MUSCULUS; RODENTIA;

EID: 0030974045     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339702500220     Document Type: Article

References (3)

1. Ashby J. and Paton D. (1995). Chemicals for evaluating the sensitivity and specificity of reduced/transgenic rodent cancer bioassay products. Mutation Res. 331: 27-38.
2. Ashby J., Short JM, Jones NJ, Lefevre PA, Provost GS, Rogers BJ, Martin LA, Parry JM, Burnette K., Glickman BW, and Tinwell H. (1994). Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: Absence of 14C or 32P bladder DNA adduction. Carcinogenesis 15(10): 2291-2296.
3. Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103(10): 942-951.